Regulatory roundup: Alexion ALS drug sees approval prospects plummet - Clinical Trials Arena

Retrieved on: 2021-08-31 14:37:30

Tags for this article:

Health sciences

Health

Clinical trials

Medical research

Clinical research

Pharmaceutical industry

Design of experiments

Food and Drug Administration

ClinicalTrials.gov

Click the tags to see associated articles and topics

Regulatory roundup: Alexion ALS drug sees approval prospects plummet - Clinical Trials Arena. View article details on HISWAI: https://www.clinicaltrialsarena.com/analysis/alexion-als-regulatory-roundup/

Excerpt

Trial termination sinks Alexion's Ultomiris approval chances in ALS · Trial resumption puts Vyriad's Voyager-1 back in the oncology game · Abridged Phase I study ...

Article found on: www.clinicaltrialsarena.com

View Original Article